Autoimmune complications of immunotherapy: pathophysiology and management

AbstractImmune checkpoint inhibitors (ICIs) are monoclonal antibodies that target inhibitory molecules, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1…


Read Original Article: Autoimmune complications of immunotherapy: pathophysiology and management »